Abstract:Introduction: The risk of alcoholic cirrhosis increases in a dose- and time-dependent manner with alcohol consumption and ethanol metabolism in the liver. Currently, no effective antifibrotic therapies are available. We aimed to obtain a better understanding of the cellular and molecular mechanisms involved in the pathogenesis of liver cirrhosis. Methods: We performed single-cell RNA-sequencing to analyze immune cells from the liver tissue and peripheral blood form patients with alcoholic cirrhosis and healthy controls to profile the transcriptomes of more than 100,000 single human cells and yield molecular definitions for non-parenchymal cell types. In addition, we performed single-cell RNA-sequencing analysis to reveal the immune microenvironment related to alcoholic liver cirrhosis. Hematoxylin and eosin, Immunofluorescence staining and Flow cytometric analysis were employed to study the difference between tissues and cells with or without alcoholic cirrhosis. Results: We identified a fibrosis-associated M1 subpopulation of macrophages that expands in liver fibrosis, differentiates from circulating monocytes, and is pro-fibrogenic. We also define mucosal-associated invariant T (MAIT) cells that expand in alcoholic cirrhosis and are topographically restricted to the fibrotic niche. Multilineage modeling of ligand and receptor interactions between the fibrosis-associated macrophages, MAIT, and NK cells revealed the intra-fibrotic activity of several pro-fibrogenic pathways, including responses to cytokines and antigen processing and presentation, natural killer cell-mediated cytotoxicity, cell adhesion molecules, Th1/Th2/Th17 cell differentiation, IL-17 signaling pathway, and Toll-like receptor signaling pathway. Discussion: Our work dissects unanticipated aspects of the cellular and molecular basis of human organ alcoholic fibrosis at the single-cell level and provides a conceptual framework for the discovery of rational therapeutic targets in liver alcoholic cirrhosis.

Recent Insights Into the Role of Immune Cells in Alcoholic Liver Disease

Noncoding RNAs in Alcoholic Liver Disease

Hepatic stellate cells and innate immunity in alcoholic liver disease

Myeloid Cells in Alcoholic Liver Diseases: Mechanism and Prospect

Single-cell Profiling of Intrahepatic Immune Cells Reveals an Expansion of Tissue-resident Cytotoxic CD4+ T Lymphocyte Subset Associated With Pathogenesis of Alcoholic-associated Liver Diseases

Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease

Analysis of Differentially Expressed Genes and Micrornas in Alcoholic Liver Disease

Dysregulation of innate cell types in the hepatic immune microenvironment of alcoholic liver cirrhosis

Role of Inflammatory Factors in Development and Progression of Alcoholic Liver Disease

Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease

Alcohol and the mechanisms of liver disease

Roles of Gut Microbiota in Alcoholic Liver Disease

New insights into the bile acid-based regulatory mechanisms and therapeutic perspectives in alcohol-related liver disease

Immune microenvironment in alcoholic liver disease and advances in targeted therapy

The Role of IL-17 Signaling in Regulation of the Liver–Brain Axis and Intestinal Permeability in Alcoholic Liver Disease

Targeting Inflammation for the Treatment of Alcoholic Liver Disease.

Advancements in the Alcohol-Associated Liver Disease Model

The role of gut microbiota, exosomes, and their interaction in the pathogenesis of ALD

Critical Roles of Kupffer Cells in the Pathogenesis of Alcoholic Liver Disease: from Basic Science to Clinical Trials

Pathogenesis and Therapeutic Value

Intestinal Microbiotas and Alcoholic Hepatitis: Pathogenesis and Therapeutic Value.